These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

161 related articles for article (PubMed ID: 26251034)

  • 1. The molecular landscape of premenopausal breast cancer.
    Liao S; Hartmaier RJ; McGuire KP; Puhalla SL; Luthra S; Chandran UR; Ma T; Bhargava R; Modugno F; Davidson NE; Benz S; Lee AV; Tseng GC; Oesterreich S
    Breast Cancer Res; 2015 Aug; 17():104. PubMed ID: 26251034
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Differential expression of progesterone receptor, FOXA1, GATA3, and p53 between pre- and postmenopausal women with estrogen receptor-positive breast cancer.
    Hosoda M; Yamamoto M; Nakano K; Hatanaka KC; Takakuwa E; Hatanaka Y; Matsuno Y; Yamashita H
    Breast Cancer Res Treat; 2014 Apr; 144(2):249-61. PubMed ID: 24549642
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Quantitative image analysis of estrogen and progesterone receptors as a prognostic tool for selecting breast cancer patients for therapy.
    Castagnetta LA; Traina A; Liquori M; Marasà L; Amodio R; Di Falco M; Miele M; Rausa L; Carruba G
    Anal Quant Cytol Histol; 1999 Feb; 21(1):59-62. PubMed ID: 10068777
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Proportion of premenopausal and postmenopausal breast cancers attributable to known risk factors: Estimates from the E3N-EPIC cohort.
    Dartois L; Fagherazzi G; Baglietto L; Boutron-Ruault MC; Delaloge S; Mesrine S; Clavel-Chapelon F
    Int J Cancer; 2016 May; 138(10):2415-27. PubMed ID: 26756677
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Expression of estrogen and progesterone receptors in human ductal invasive breast carcinoma not otherwise specified: is there any difference between premenopausal and postmenopausal women?
    Petricević J; Petković M; Jonjić N
    Acta Clin Croat; 2011 Jun; 50(2):169-75. PubMed ID: 22263379
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Integrative molecular profiling identifies a novel cluster of estrogen receptor-positive breast cancer in very young women.
    Park C; Yoon KA; Kim J; Park IH; Park SJ; Kim MK; Jang W; Cho SY; Park B; Kong SY; Lee ES
    Cancer Sci; 2019 May; 110(5):1760-1770. PubMed ID: 30811755
    [TBL] [Abstract][Full Text] [Related]  

  • 7. High Ki-67 Expression and Low Progesterone Receptor Expression Could Independently Lead to a Worse Prognosis for Postmenopausal Patients With Estrogen Receptor-Positive and HER2-Negative Breast Cancer.
    Nishimukai A; Yagi T; Yanai A; Miyagawa Y; Enomoto Y; Murase K; Imamura M; Takatsuka Y; Sakita I; Hatada T; Miyoshi Y
    Clin Breast Cancer; 2015 Jun; 15(3):204-11. PubMed ID: 25600243
    [TBL] [Abstract][Full Text] [Related]  

  • 8. SERPINA1 is a direct estrogen receptor target gene and a predictor of survival in breast cancer patients.
    Chan HJ; Li H; Liu Z; Yuan YC; Mortimer J; Chen S
    Oncotarget; 2015 Sep; 6(28):25815-27. PubMed ID: 26158350
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Clinicopathological factors predicting early and late distant recurrence in estrogen receptor-positive, HER2-negative breast cancer.
    Yamashita H; Ogiya A; Shien T; Horimoto Y; Masuda N; Inao T; Osako T; Takahashi M; Endo Y; Hosoda M; Ishida N; Horii R; Yamazaki K; Miyoshi Y; Yasojima H; Tomioka N;
    Breast Cancer; 2016 Nov; 23(6):830-843. PubMed ID: 26467036
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Aging impacts transcriptomes but not genomes of hormone-dependent breast cancers.
    Yau C; Fedele V; Roydasgupta R; Fridlyand J; Hubbard A; Gray JW; Chew K; Dairkee SH; Moore DH; Schittulli F; Tommasi S; Paradiso A; Albertson DG; Benz CC
    Breast Cancer Res; 2007; 9(5):R59. PubMed ID: 17850661
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Body mass index is associated with gene methylation in estrogen receptor-positive breast tumors.
    Hair BY; Troester MA; Edmiston SN; Parrish EA; Robinson WR; Wu MC; Olshan AF; Swift-Scanlan T; Conway K
    Cancer Epidemiol Biomarkers Prev; 2015 Mar; 24(3):580-6. PubMed ID: 25583948
    [TBL] [Abstract][Full Text] [Related]  

  • 12. GATA3 mutations define a unique subtype of luminal-like breast cancer with improved survival.
    Jiang YZ; Yu KD; Zuo WJ; Peng WT; Shao ZM
    Cancer; 2014 May; 120(9):1329-37. PubMed ID: 24477928
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A refined molecular taxonomy of breast cancer.
    Guedj M; Marisa L; de Reynies A; Orsetti B; Schiappa R; Bibeau F; MacGrogan G; Lerebours F; Finetti P; Longy M; Bertheau P; Bertrand F; Bonnet F; Martin AL; Feugeas JP; Bièche I; Lehmann-Che J; Lidereau R; Birnbaum D; Bertucci F; de Thé H; Theillet C
    Oncogene; 2012 Mar; 31(9):1196-206. PubMed ID: 21785460
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The Association of Modifiable Breast Cancer Risk Factors and Somatic Genomic Alterations in Breast Tumors: The Cancer Genome Atlas Network.
    Heng YJ; Hankinson SE; Wang J; Alexandrov LB; Ambrosone CB; de Andrade VP; Brufsky AM; Couch FJ; King TA; Modugno F; Vachon CM; Eliassen AH; Tamimi RM; Kraft P
    Cancer Epidemiol Biomarkers Prev; 2020 Mar; 29(3):599-605. PubMed ID: 31932411
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Phytoestrogen intake from foods, during adolescence and adulthood, and risk of breast cancer by estrogen and progesterone receptor tumor subgroup among Ontario women.
    Anderson LN; Cotterchio M; Boucher BA; Kreiger N
    Int J Cancer; 2013 Apr; 132(7):1683-92. PubMed ID: 22907507
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Comparison of HER-2/neu, ER and PCNA expression in premenopausal and postmenopausal patients with breast carcinoma.
    Zheng W; Zheng J; Ma L; Meng F; Huang L; Ma D
    APMIS; 2005 Mar; 113(3):175-81. PubMed ID: 15799760
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The importance of individual biology in the clinical use of serum biomarkers for ovarian cancer.
    Braga F; Ferraro S; Mozzi R; Panteghini M
    Clin Chem Lab Med; 2014 Nov; 52(11):1625-31. PubMed ID: 24829196
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Body weight and incidence of breast cancer defined by estrogen and progesterone receptor status--a meta-analysis.
    Suzuki R; Orsini N; Saji S; Key TJ; Wolk A
    Int J Cancer; 2009 Feb; 124(3):698-712. PubMed ID: 18988226
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Antitumor activity of chemoendocrine therapy in premenopausal and postmenopausal models with human breast cancer xenografts.
    Kataoka M; Yamaguchi Y; Moriya Y; Sawada N; Yasuno H; Kondoh K; Evans DB; Mori K; Hayashi S
    Oncol Rep; 2012 Feb; 27(2):303-10. PubMed ID: 22076074
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Breast Tumor Prognostic Characteristics and Biennial vs Annual Mammography, Age, and Menopausal Status.
    Miglioretti DL; Zhu W; Kerlikowske K; Sprague BL; Onega T; Buist DS; Henderson LM; Smith RA;
    JAMA Oncol; 2015 Nov; 1(8):1069-77. PubMed ID: 26501844
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.